JMD ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tubbs, R. R.
Right arrow Articles by Grogan, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tubbs, R. R.
Right arrow Articles by Grogan, T.
JMD 2000, Vol. 2, No. 2
Copyright © 2000 American Society for Investigative Pathology & Association for Molecular Pathology

Concomitant Oncoprotein Detection with Fluorescence in Situ Hybridization (CODFISH)

A Fluorescence-Based Assay Enabling Simultaneous Visualization of Gene Amplification and Encoded Protein Expression

Raymond R. Tubbs*, James Pettay*, Pat Roche{dagger}, Mark H. Stoler§, Robert Jenkins{dagger}, Jon Myles* and Thomas Grogan{ddagger}

From the Departments of Clinical and Anatomic Pathology, * the Cleveland Clinic Foundation, Cleveland, Ohio; the Department of Laboratory Medicine and Pathology, {dagger} Mayo Clinic, Rochester, Minnesota; the Department of Pathology, {ddagger} University of Arizona School of Medicine, Tucson, Arizona; and the Robert E. Fechner Laboratory of Surgical Pathology, § University of Virginia School of Medicine, Charlottesville, Virginia

We sought the validation of a three-color fluorescence-based system that simultaneously profiles Her-2/neu oncogene copy by fluorescence in situ hybridization (FISH) and Her-2/neu encoded protein by the use of a versatile alkaline phosphatase chromogen fast red K in either fluorescence or bright-field mode. Nuclei were counterstained with DAPI. Nineteen infiltrating ductal carcinomas of breast were comprehensively evaluated for Her-2/neu amplification/overexpression by direct and indirect FISH using digoxigenin (DigFISH) and direct fluorescently labeled probes, autoradiographic RNA:RNA in situ hybridization, and immunohistochemistry using monoclonal antibody CB11. CODFISH results correlated well with DigFISH, direct-label FISH, mRNA expression, and oncoprotein expression as assessed with CB11, and enabled simultaneous visualization of gene copy and protein. In addition, qualitative immunohistochemistry may be followed by CODFISH gene copy enumeration to clarify ambiguous cases.




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
R. Tubbs, J. Pettay, M. Skacel, R. Powell, M. Stoler, P. Roche, and J. Hainfeld
Gold-Facilitated in Situ Hybridization : A Bright-Field Autometallographic Alternative to Fluorescence in Situ Hybridization for Detection of HER-2/neu Gene Amplification
Am. J. Pathol., May 1, 2002; 160(5): 1589 - 1595.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
S A J Vaziri, R R Tubbs, G Darlington, and G Casey
Absence of CCND1 gene amplification in breast tumours of BRCA1 mutation carriers
Mol. Pathol., August 1, 2001; 54(4): 259 - 263.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Society for Investigative Pathology and the Association for Molecular Pathology.